Abstract:Background and Aims: Metastasis is the major cause of death in patients with colorectal carcinoma (CRC).Thyroid hormone receptor interacting protein 6 (TRIP6) is an adaptor protein that regulates cell motility and anti-apoptotic signaling.This study aimed to elucidate the biological function and molecular mechanism of TRIP6 in CRC metastasis.Methods: TRIP6 expression was assessed in 226 paired human CRC tumor and adjacent non-tumor tissues, and 15 paired primary and metastatic CRC by RT-qPCR and immunohistochemistry from our cohort, and validated in TCGA cohort (n=286).Function of TRIP6 in metastasis was studied in vitro and in vivo.TRIP6 related pathways were identified by RNA-sequencing, pathway luciferase reporter assays and western blot.Protein interaction of TRIP6 and its downstream effectors was identified by co-immunoprecipitation (co-IP).Colonic epithelial cell tight junction was assessed by transmission electron microscope (TEM).Results: TRIP6 mRNA and protein were significantly up-regulated in CRC tumors compared to adjacent normal tissues in our cohort I (n=150, P<0.0001) and cohort II (n=76, P<0.0001) of CRC primary patients, as well as in TCGA cohort (n=286, P<0.0001).A more pronounced TRIP6 expression was demonstrated in CRC liver metastasis lesions compared to primary CRC tissues (n=15, P<0.0001).TRIP6 disrupted the integrity of tight junction in CRC by directlyinteracting critical tight junction-associated PDZ domain-containing proteins (PARD3, ZO-1, ZO-3 and MAGI1) in colon cancer cell lines by co-IP and immunofluorescence staining.Ectopic expression of TRIP6 in colon cancer cell lines (DLD1 and SW480) significantly promoted cell migration and invasion ability in vitro (all P<0.01) through inducing EMTmetastasis genes.In keeping with the in vitro findings, ectopic expression of TRIP6 in SW480 cells promoted colorectal cancer liver metastasis in nude mice, along with disrupted colonic epithelial cell tight junction by TEM.Moreover, TRIP6 promoted colon cancer cells growth in liver microenvironment.The pro-metastatic effect by TRIP6 was depending on the tight junction-associated PDZ domain-containing protein.On the other hand, knockdown of TRIP6 in HCT116 and SW1116 cells inhibited cell migration ( P<0.01) and invasion (P<0.001)abilities and suppressed liver metastasis in nude mice compared to control group ( P<0.001).Mechanistically, TRIP6 activated AKT/HIF1a signaling as identified by RNA-sequencing and confirmed by increased hypoxia response element (HRE) reporter activity ( P<0.01), enhanced p-Akt and HIF1a and decreased PTEN protein expression.Conclusion: TRIP6 is commonly overexpressed in CRC and more pronounced in liver metastasis.TRIP6 promotes metastasis by directly targeting tight junction-associated proteins to disrupt colonic epithelial cell integrity and byactivating AKT/HIF1a cascade.

TRAF6 Inhibits Colorectal Cancer Metastasis Through Regulating Selective Autophagic CTNNB1/β-catenin Degradation and is Targeted for GSK3B/GSK3β-mediated Phosphorylation and Degradation.

TRAF6 regulates the signaling pathway influencing colorectal cancer function through ubiquitination mechanisms

TRAF6 Regulates YAP Signaling by Promoting the Ubiquitination and Degradation of MST1 in Pancreatic Cancer

TRAF6 is Upregulated in Colon Cancer and Promotes Proliferation of Colon Cancer Cells

SPHK1 potentiates colorectal cancer progression and metastasis via regulating autophagy mediated by TRAF6-induced ULK1 ubiquitination

Sa1172 TRIP6-DEPENDENT ACTIVATION OF AKT/HIF1A CASCADE PROMOTES COLORECTAL CANCER METASTASIS BY DISRUPTING THE INTEGRITY OF CELL TIGHT JUNCTIONS

TRAF6 Regulates EGF-induced Cell Transformation and Cscc Malignant Phenotype Through CD147/EGFR

TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host

Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling

TRAF6 Regulates Melanoma Invasion and Metastasis Through Ubiquitination of Basigin

TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma.

TRAF6 Enhances PD-L1 Expression Through YAP1-TFCP2 Signaling in Melanoma

TRAF6 is Over-Expressed in Pancreatic Cancer and Promotes the Tumorigenicity of Pancreatic Cancer Cells

Silencing CXCR6 Promotes Epithelial-Mesenchymal Transition and Invasion in Colorectal Cancer by Activating the VEGFA/PI3K/AKT/mTOR Pathway

TRAF6 Restricts P53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression.

TRAF6 Promoted the Tumorigenicity of Esophageal Squamous Cell Carcinoma

Tumor Necrosis Factor Receptor-Associated Factor 6 Contributes to Malignant Behavior of Human Cancers Through Promoting AKT Ubiquitination and Phosphorylation

TRAF6 regulates autophagy and apoptosis of melanoma cells through c-Jun/ATG16L2 signaling pathway

1222 TRAF6 Regulates Autophagy and Apoptosis of Melanoma Cells Through C-Jun/atg16l2 Signaling Pathway

TRAF6 promotes TGFβ-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGFβ type I receptor

TRAF6 promotes chemoresistance to paclitaxel of triple negative breast cancer via regulating PKM2‐mediated glycolysis